No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Cuts Target Price to $175
Express News | J&J : Citigroup Cuts Target Price to $175 From $185
Investors in Johnson & Johnson (NYSE:JNJ) Have Unfortunately Lost 4.4% Over the Last Three Years
Why Is Johnson & Johnson (JNJ) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?
BofA Restarts Coverage of 11 Large-cap Biopharmas
GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex